drugset / Trial / NCT02778919
Late Phase II Clinical Study of KLH-2109 in Patients With Endometriosis
Summary
The purpose of this study is to evaluate the efficacy, safety, and dose-response relationship of KLH-2109 compared to placebo in Japanese patients with endometriosis.
Timeline
- Start
- 2016-05-09
- Primary completion
- 2018-03-23
- Completion
- 2018-03-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KLH-2109 | Unknown | — | — |
| Subject | Leuprolide | Other / unclassified | — | — |